Fox Chase Cancer Center News

PHILADELPHIA (November 28, 2023) — Sanjay S. Reddy, MD, FACS, Co-Director of the Marvin & Concetta Greenberg Pancreatic Institute and an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, was recently appointed to a volunteer position with the American Board of Surgery and a position with the Society of Surgical Oncology.

PHILADELPHIA (November 27, 2023) — Four physicians from Ukraine who specialize in the treatment of cancer ended a recent visit to Fox Chase Cancer Center by discussing the challenges they faced delivering care during wartime.

PHILADELPHIA (November 13, 2023) — Edna “Eti” Cukierman, PhD, Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute and Co-Leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently awarded the American Cancer Society’s (ACS) Wilmott Family Professorship in Pancreatic Cancer.

PHILADELPHIA (November 9, 2023) —

PHILADELPHIA (November 9, 2023) — Alexander Kutikov, MD, FACS, Chair of the Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, will receive the Andrew C. Novick Award from the Kidney Cancer Association.

PHILADELPHIA (November 2, 2023) — Lewis Katz School of Medicine/Fox Chase Cancer Center and Hunter College of the City University of New York have received a five-year, $13.3 million competitive grant renewal from the National Cancer Institute (NCI), part of the National Institutes of Health, to address cancer health disparities.

PHILADELPHIA (October 30, 2023) — Henkel Valentine, PhD, a postdoctoral fellow in the lab of Philip Abbosh, MD, PhD, in the Nuclear Dynamics and Cancer Research Program at Fox Chase Cancer Center, was one of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

PHILADELPHIA (October 30, 2023) — A majority of clinicians with expertise in hereditary gastroenterology support implementing genetic screening known as universal germline testing for the diagnosis of colorectal cancer, according to the results of a clinical practice survey conducted by Sanjeevani Arora, PhD, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center.